Question 1

How many shares of VTGN does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 345,432 shares of VTGN (VISTAGEN THERAPEUTICS INC).

Question 2

What is BlackRock, Inc.'s VTGN position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s VTGN position is worth $78,068.

Question 3

Is BlackRock, Inc. buying or selling VTGN?

Accepted Answer

In 2026-Q2, BlackRock, Inc. decreased their VTGN position (-23.0% change in shares).

Question 4

When did BlackRock, Inc. first buy VTGN?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in VTGN in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	345,432	-23.0%	$78,068	0.0%	$0.23	0
2026-Q1	Increased	448,507	+6.1%	$256,322	0.0%	$0.61	17
2025-Q4	Decreased	422,759	-0.1%	$279,824	0.0%	$0.68	0
2025-Q3	Increased	423,128	+1.5%	$1.5M	0.0%	$3.54	18
2025-Q2	Increased	416,889	+0.1%	$833,778	0.0%	$1.97	17
2025-Q1	Increased	416,338	+1.2%	$1M	0.0%	$2.59	17
2024-Q4	New	411,553	-	$1.2M	0.0%	$2.81	39

VTGN7 quarters

VTGN
7 quarters